Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Virgin Galactic Is Still Far Too Risky At Today’s Prices

By Thomas Niel, InvestorPlace Contributor
Investors may be cutting SPCE stock some slack, but many hurdles remain. Wait for a pullback before buying into Virgin Galactic.

Call it Heresy, But It’s Time to Sell Costco

By Dana Blankenhorn, InvestorPlace Contributor
If you want to sell some stock for Christmas, consider selling some COST stock and spending the money at your nearest Costco.

Why JFrog’s Stock Is Not Very Appealing

By Larry Ramer, InvestorPlace Contributor
The valuation of FROG stock is huge, while reviews of its products are not stellar and it may lack a powerful competitive advantage.

Now Is Not a Time to Gamble on Electrameccanica Vehicles

By Chris Markoch, InvestorPlace Contributor
SOLO stock is soaring as Electrameccanica Vehicles prepares to open a U.S. manufacturing facility. But the question remains if the company is a fad?

McDonald’s Gives Beyond Meat Stock the Cold Shoulder

By Will Ashworth, InvestorPlace Contributor
Beyond Meat got a reality check when McDonald’s announced its McPlant line would launch in 2021. The news pummeled Beyond Meat stock. 

Wait on Investor Rotation for Zoom Video

By Dana Blankenhorn, InvestorPlace Contributor
If you have made money on ZM stock, sell it and wait to see its long term growth rate, then calculate the value of that growth.

Don’t Chase the Current Rally of Workhorse Stock

By Joel Baglole, InvestorPlace Contributor
After falling 50% between late September and the end of October, WKHS stock appears to now be rebounding, leaving investors to ask if they believe the current rally will last.

Inovio Pharmaceutical’s FDA Plight Makes It a Highly Risky Bet

By Muslim Farooque, InvestorPlace Contributor
INO stock has tumbled in the past few months. Inovio needs the FDA to bail it out by allowing the advanced trials of its vaccine to begin.

Don’t Buy the Latest Rally in Exxon Mobil — It’s a Dinosaur

By Louis Navellier and the InvestorPlace Research Staff
XOM stock shares may have staged a late fall rally, but that does not mean Exxon Mobil is at the start of a meaningful recovery.

These 3 Companies Currently Provide Much Better Value Than Nio

By Will Ashworth, InvestorPlace Contributor
Nio stock is worth more than Daimler. It sells 1/200th the number of vehicles. Here are three companies that provide better value.

As It Flags in the 5G Race, Nokia Stock Is in for a Very Long Winter

By Muslim Farooque, InvestorPlace Contributor
Nokia stock is down this month on the back of a disappointing third quarter and its lacklustre performance in the 5G realm

Beyond Meat Stock Is Too High at 20 Times Revenue While Growth Stalls

By Mark R. Hake, CFA
Growth has slowed at Beyond Meat, so why is the stock valued like it's spiking? Beyond Meat stock is not worth its huge 20 times revenue multiples while its growth is slowing.

As Musk Battles the Coronavirus, It’s Time to Sell Tesla Stock

By Dana Blankenhorn, InvestorPlace Contributor
Elon Musk's Covid-19 diagnosis should remind investors that the biggest risk they face is his health. Take your profits in Tesla stock.

JFrog Is Still Wildly Overvalued Ahead of Insider Share Lockout Release

By Mark R. Hake, CFA
JFrog is still ridiculously overvalued ahead of its insider share lockout release. FROG stock is still trading for 29 times 2021 revenue forecasts, which is too high for most value investors.

5 Overvalued Stocks to Purge From Portfolios Before We Enter 2021

By Thomas Niel, InvestorPlace Contributor
Could these five overvalued stocks change course as the new year approaches? Consider selling BURL, CMG, PINS, RCL and W ahead of their likely declines.

7 Sin Stocks That May Face Coronavirus Headwinds

By Josh Enomoto, InvestorPlace Contributor
Given the narrative of stress release, sin stocks should perform well in this pandemic. But here are names that might struggle.

Sell Novavax Stock After Its Huge Gain

By Dana Blankenhorn, InvestorPlace Contributor
NVAX stock has a nearly $6 billion market cap based on a COVID-19 vaccine that may not work. The firm has a history of cashing in on hype.

Nikola Will Likely Keep On Losing Money, Pushing NKLA Stock Lower

By Mark R. Hake, CFA
Nikola will likely keep on losing money, pushing NKLA stock lower. It is worth over 8 times less based on its negative cash flow.

AT&T Stock’s Terrible Year Gets Slightly Better, But I Still Wouldn’t Buy It

By Louis Navellier and the InvestorPlace Research Staff
AT&T stock has performed better over the past two weeks, but there are many obstacles in the way of anything approaching a recovery.
Load More Articles